Position in ANIP
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,139
New position
Shares Held
50
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#273
of 305 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Avion Wealth holds $73,741 across 14 Drug Manufacturers - Specialty & Generic names. ANIP ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AQST |
Aquestive Therapeutics, Inc.
|
4,000 | $16,640 | |
| 2 | 5,000 | $15,800 | |||
| 3 | ZTS |
Zoetis Inc.
|
133 | $9,557 | |
| 4 | VTRS |
Viatris Inc
|
411 | $6,526 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
9 | $4,876 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
This page
|
50 | $4,139 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
118 | $2,903 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
45 | $2,877 |
All Filings in ANIP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,139 | 50 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||